Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Sep-24 5:46 PM View:  | 4d Molecular Therapeutics, ... (FDMT) | 16-Sep-24 | Option Exercise | 500 | $6.49 | $3,245.00 | 7% 6.78K to 7.28K | |
| 18-Sep-24 5:46 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 16-Sep-24 | Planned Option Sale | 500 | $16.33 | $8,165.00 | (7%) 7.28K to 6.78K | |
| 18-Jul-24 8:22 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 16-Jul-24 | Option Exercise | 1,750 | $7.60 | $13,295.00 | 26% 6.78K to 8.53K | |
| 18-Jul-24 8:22 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 16-Jul-24 | Planned Option Sale | 1,750 | $27.11 | $47,442.50 | (21%) 8.53K to 6.78K | |
| 15-Jul-24 6:13 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 11-Jul-24 | Option Exercise | 1,996 | $15.78 | $31,496.90 | 29% 6.78K to 8.78K | |
| 15-Jul-24 6:13 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 11-Jul-24 | Planned Option Sale | 1,996 | $25.00 | $49,900.00 | (23%) 8.78K to 6.78K | |
| 03-Jul-24 5:11 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 01-Jul-24 | Option Exercise | 4,248 | $7.55 | $32,089.30 | 245% 1.74K to 5.99K | |
| 03-Jul-24 5:11 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 01-Jul-24 | Planned Option Sale | 4,248 | $21.36 | $90,757.70 | (71%) 5.99K to 1.74K | |
| 20-Jun-24 4:59 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 17-Jun-24 | Option Exercise | 1,750 | $7.60 | $13,295.00 | 101% 1.74K to 3.49K | |
| 20-Jun-24 4:59 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 17-Jun-24 | Planned Option Sale | 1,750 | $23.71 | $41,493.60 | (50%) 3.49K to 1.74K | |
| 20-May-24 8:35 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 16-May-24 | Option Exercise | 1,750 | $7.60 | $13,295.00 | 101% 1.74K to 3.49K | |
| 20-May-24 8:35 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 16-May-24 | Planned Option Sale | 1,750 | $25.45 | $44,541.00 | (50%) 3.49K to 1.74K | |
| 18-Apr-24 8:48 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 16-Apr-24 | Option Exercise | 1,750 | $7.60 | $13,295.00 | 101% 1.74K to 3.49K | |
| 18-Apr-24 8:48 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 16-Apr-24 | Planned Option Sale | 1,750 | $25.74 | $45,045.00 | (50%) 3.49K to 1.74K | |
| 03-Apr-24 7:18 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 01-Apr-24 | Option Exercise | 8,153 | $12.54 | $102,224.00 | 469% 1.74K to 9.89K | |
| 03-Apr-24 7:18 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 01-Apr-24 | Planned Option Sale | 8,153 | $31.78 | $259,102.00 | (82%) 9.89K to 1.74K | |
| 29-Mar-24 4:52 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 27-Mar-24 | Option Exercise | 5,833 | $25.98 | $151,541.00 | 336% 1.74K to 7.57K | |
| 29-Mar-24 4:52 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 27-Mar-24 | Planned Option Sale | 5,833 | $35.04 | $204,410.00 | (77%) 7.57K to 1.74K | |
| 20-Mar-24 4:40 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 18-Mar-24 | Option Exercise | 1,750 | $7.60 | $13,295.00 | 101% 1.74K to 3.49K | |
| 20-Mar-24 4:40 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 18-Mar-24 | Planned Option Sale | 1,750 | $31.27 | $54,722.50 | (50%) 3.49K to 1.74K | |
| 29-Feb-24 6:01 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 27-Feb-24 | Option Exercise | 1,909 | $20.24 | $38,638.20 | 110% 1.74K to 3.65K | (10%) |
| 29-Feb-24 6:01 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 27-Feb-24 | Planned Private Option Sale | 1,909 | $30.00 | $57,270.00 | (52%) 3.65K to 1.74K | |
| 21-Feb-24 5:41 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 16-Feb-24 | Option Exercise | 1,750 | $7.60 | $13,295.00 | 101% 1.74K to 3.49K | |
| 21-Feb-24 5:41 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 16-Feb-24 | Planned Option Sale | 1,750 | $27.67 | $48,422.50 | (50%) 3.49K to 1.74K | |
| 12-Feb-24 9:04 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 08-Feb-24 | Option Exercise | 6,244 | $10.18 | $63,586.20 | 359% 1.74K to 7.98K | |
| 12-Feb-24 9:04 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 08-Feb-24 | Planned Option Sale | 6,244 | $27.50 | $171,710.00 | (78%) 7.98K to 1.74K | |
| 12-Jun-23 6:23 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 08-Jun-23 | Option Exercise | 3,750 | $8.04 | $30,150.00 | 216% 1.74K to 5.49K | |
| 12-Jun-23 6:23 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 08-Jun-23 | Planned Option Sale | 3,750 | $20.85 | $78,187.50 | (68%) 5.49K to 1.74K | |
| 25-Apr-23 6:44 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 21-Apr-23 | Option Exercise | 3,750 | $8.04 | $30,150.00 | 178% 2.11K to 5.86K | |
| 25-Apr-23 6:44 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 21-Apr-23 | Planned Option Sale | 3,750 | $20.00 | $75,000.00 | (64%) 5.86K to 2.11K | |
| 03-Mar-23 6:16 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 01-Mar-23 | Option Exercise | 1,875 | $6.49 | $12,168.80 | 76% 2.48K to 4.36K | |
| 03-Mar-23 6:16 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 01-Mar-23 | Planned Option Sale | 1,875 | $19.30 | $36,187.50 | (43%) 4.36K to 2.48K | |
| 03-Mar-23 6:16 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 01-Mar-23 | Sale (Planned) | 373 | $19.30 | $7,198.90 | (15%) 2.48K to 2.11K | |
| 05-Dec-22 5:33 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 01-Dec-22 | Option Exercise | 5,625 | $7.52 | $42,318.80 | 197% 2.86K to 8.48K | |
| 05-Dec-22 5:33 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 01-Dec-22 | Planned Option Sale | 5,625 | $22.79 | $128,180.00 | (66%) 8.48K to 2.86K | |
| 05-Dec-22 5:33 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 01-Dec-22 | Sale (Planned) | 375 | $22.79 | $8,545.31 | (13%) 2.86K to 2.48K |